These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies. Salvoza N; Giraudi P; Gazzin S; Bonazza D; Palmisano S; de Manzini N; Zanconati F; Raseni A; Sirianni F; Tiribelli C; Rosso N J Transl Med; 2023 Dec; 21(1):906. PubMed ID: 38082368 [TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. Abushamat LA; Shah PA; Eckel RH; Harrison SA; Barb D Clin Gastroenterol Hepatol; 2024 Aug; 22(8):1565-1574. PubMed ID: 38367743 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD-A Pilot Study. Zyśk B; Ostrowska L; Smarkusz-Zarzecka J; Orywal K; Mroczko B; Cwalina U Nutrients; 2024 May; 16(9):. PubMed ID: 38732626 [TBL] [Abstract][Full Text] [Related]
11. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Sandireddy R; Sakthivel S; Gupta P; Behari J; Tripathi M; Singh BK Front Cell Dev Biol; 2024; 12():1433857. PubMed ID: 39086662 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants. Bril F; Kalavalapalli S; Lomonaco R; Frye R; Godinez Leiva E; Cusi K JHEP Rep; 2024 Jul; 6(7):101092. PubMed ID: 39022386 [TBL] [Abstract][Full Text] [Related]
14. Incretin-based investigational therapies for the treatment of MASLD/MASH. Brouwers B; Rao G; Tang Y; Rodríguez Á; Glass LC; Hartman ML Diabetes Res Clin Pract; 2024 May; 211():111675. PubMed ID: 38636848 [TBL] [Abstract][Full Text] [Related]
15. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes. Castellano-Castillo D; Núñez-Sánchez MÁ; Balaguer-Román A; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Martínez CM; Frutos MD; Queipo-Ortuño MI; Cardona F; Ramos-Molina B Surg Obes Relat Dis; 2024 Jul; 20(7):652-659. PubMed ID: 38490825 [TBL] [Abstract][Full Text] [Related]
16. The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis. Burmeister Y; Weyer K; Dörre A; Seilheimer B Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137437 [TBL] [Abstract][Full Text] [Related]
17. Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study. Valenzuela-Vallejo L; Chrysafi P; Kouvari M; Guatibonza-Garcia V; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; Mingrone G; George J; Mantzoros CS Metabolism; 2023 Nov; 148():155694. PubMed ID: 37757973 [TBL] [Abstract][Full Text] [Related]
18. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome. Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146 [TBL] [Abstract][Full Text] [Related]
19. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice. Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323 [TBL] [Abstract][Full Text] [Related]
20. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19. Jacobs AK; Morley SD; Samuel K; Morgan K; Boswell L; Kendall TJ; Dorward DA; Fallowfield JA; Hayes PC; Plevris JN World J Gastroenterol; 2024 Aug; 30(31):3705-3716. PubMed ID: 39192998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]